- Lobbying
- Lobbying by Novo Nordisk Inc.
Lobbying Relationship
Bills mentioned
H.R.4818: Treat and Reduce Obesity Act of 2023
Sponsor: Brad Wenstrup (R-Ohio)
S.2407: Treat and Reduce Obesity Act of 2023
Sponsor: Thomas R. Carper (D-Del.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Bill Ghent | Chief of Staff, Legislative Director, Communications Director - Sen. Tom Carper |
Steven Elmendorf | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
Medicare
U.S. Senate
Medicare
U.S. Senate
Medicare
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate